4/16/2019
Poll question: Is price regulation the answer for biologic drug costs?
56.25%
The regulation of prices for post-exclusivity biologic drugs is worth exploring.
25%
The health care system has more to fear from price regulation than high costs.
18.75%
The biosimilar system needs more time but will lower costs.